UnitedHealth Group Incorporated (UNH) is a diversified health care and well-being company headquartered in Eden Prairie, Minnesota. It is best known as the largest health insurance provider in the United States, but its business extends well beyond insurance into care delivery, pharmacy services, data analytics, and health technology. Because of its size and reach across payers, providers, employers, and government programs, the company is closely watched as a bellwether for the U.S. healthcare sector and the broader market. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
UnitedHealth Group traces its origins to 1974, when it began as an early health maintenance organization (HMO) — a managed-care model that coordinates coverage and care delivery. The business was restructured as United HealthCare Corporation in 1977 and went public in 1984, growing over decades through both organic expansion and a long series of acquisitions. In 1998, United HealthCare Corporation became a subsidiary of a reorganized parent, UnitedHealth Group.
The company's business model rests on two complementary platforms that work together while serving different parts of the healthcare value chain.
UnitedHealthcare is the health benefits arm, offering employer-sponsored, individual, Medicare, Medicaid, and other benefit plans. It is organized into business lines including Employer & Individual, Medicare & Retirement, and Community & State. This segment generates the majority of the company's revenue, primarily through insurance premiums and service fees.
Optum is the health services platform, created in 2011 and generally the faster-growing part of the business. Optum is divided into three businesses:
This structure gives UnitedHealth Group a distinctive market position: it is both a major payer and a provider of the services that payers, doctors, and governments use. The company's scale is significant, with annual revenue of roughly $450 billion in recent years, a workforce numbering in the hundreds of thousands, and a ranking among the largest U.S. corporations by revenue.
UNH attracts investor attention for several long-term reasons. First, its diversified financial profile spans insurance, care delivery, pharmacy, and technology, which can help balance performance across different parts of the healthcare economy. Second, the company benefits from demographic tailwinds, including an aging population that drives demand for Medicare-related coverage and services. From what I see, the Optum platform stands out because it serves both UnitedHealthcare's own members and external clients, positioning the company to capture value beyond insurance premiums.
UnitedHealth Group's scale and data capabilities also support cost-management and care-coordination efforts, which are central to modern healthcare economics. As a Dow Jones Industrial Average component, the company's results are also followed as an indicator of broader U.S. corporate and consumer health trends. I often reference Tickeron’s AI Trend Prediction Engine when assessing longer-term movements in names like this.
Investors should understand several factors that can affect UnitedHealth Group. The business is heavily exposed to government programs such as Medicare and Medicaid, making it sensitive to changes in reimbursement rates, regulation, and public policy. Healthcare is also a highly competitive industry, with rivals across insurance, pharmacy benefit management, and care delivery.
Operationally, the company faces medical cost trends and utilization patterns that can pressure margins, as well as scrutiny of claim-denial practices and other consumer-facing policies. Its acquisition-driven history has periodically drawn antitrust attention, and it must manage cybersecurity and data-privacy risks given the sensitive health information it handles. Finally, as a large, diversified healthcare enterprise, its results can be affected by broader macroeconomic conditions, labor costs, and legal or reputational developments. One thing that stands out here is the need to monitor policy shifts closely.
UnitedHealth Group is unique for operating at the intersection of health insurance and health services, pairing one of the nation's largest benefit platforms with a rapidly growing services and technology business in Optum. That dual structure gives the company broad reach across patients, providers, employers, and government programs. For investors, UNH remains a closely followed name because its scale and diversification make it both a major healthcare enterprise and a widely watched indicator of trends across the U.S. healthcare system.
In my own analysis, I frequently turn to Tickeron’s AI Screener to screen for comparable healthcare names and refine my views on valuation and momentum. It helps surface ideas based on technical indicators, fundamentals, and AI signals without replacing my own judgment. This kind of tool has become a regular part of how I cross-check sector positioning before forming conclusions on holdings like UNH.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
UNH saw its Momentum Indicator move below the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 58 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 70%.
The 10-day RSI Indicator for UNH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 18 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 51%.
The Moving Average Convergence Divergence Histogram (MACD) for UNH turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 27 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
UNH broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
UNH moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for UNH crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +2.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNH advanced for three days, in 186 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 109 of 245 cases where UNH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 44%.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating fairly steady price growth. UNH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.594) is normal, around the industry mean (3.520). P/E Ratio (25.266) is within average values for comparable stocks, (126.353). Projected Growth (PEG Ratio) (1.025) is also within normal values, averaging (0.786). UNH has a moderately high Dividend Yield (0.024) as compared to the industry average of (0.009). P/S Ratio (0.757) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of hospital and medical service plans
Industry ManagedHealthCare